Purpose. To investigate the permeability and localization of topically appl
ied I-125-TGF-beta 3 in porcine floor-of-mouth mucosa as a function of conc
entration and exposure.
Methods. The I-125-TGF-beta 3 diluted in three different vehicles was appli
ed to the tissue samples mounted in perfusion cells maintained at 37 degree
s C. Flux and K-p values were calculated from the perfusate collected over
a 24 hour period. The quantity of I-125-TGF-beta 3 present in the tissue wa
s determined by horizontal sectioning and subsequent counting. The stabilit
y of I-125-TGF-beta 3 in saliva and in the tissue was analyzed by SDS polya
crylamide gradient gel electrophoresis.
Results. I-125-TGF-beta 3 was relatively stable in saliva and in the epithe
lium; approximately 50% of the total counts in the deeper epithelium were r
esident in the 25kDa TGF-beta 3 homodimer. A steady-state flux was reached
similar to 6 hours post application and K-p value was 4.0 +/- 0.6 x 10(-6)
(mean +/- sem). Penetration of I-125-TGF-beta 3 to the basal cell layer was
concentration dependent but reached nanomolar concentrations even after ex
tensive surface rinsing, representing over one-thousand fold the IC50 for e
pithelial cell cycle arrest.
Conclusions. The data suggest that topical application of TGF-beta 3 to the
oral mucosa in an appropriate vehicle can provide effective therapeutic de
livery to the tissue.